Expanding Brain Monitoring Technology to Novel Industries and Applications

Publication ID: 24-11857334_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Expanding Brain Monitoring Technology to Novel Industries and Applications,” Published Technical Disclosure No. 24-11857334_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857334_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,334.

Summary of the Inventive Concept

This inventive concept leverages the core technology of monitoring brain activity to address pressing needs in various industries, including sports, transportation, healthcare, and aviation. By applying electroencephalogram (EEG) and other measurements, our concept enables the detection of cognitive impairment, fatigue, neuroplasticity, mental workload, and anxiety disorders in diverse settings.

Background and Problem Solved

The original patent focused on monitoring subjects under the influence of drugs. However, the limitations of this technology lie in its narrow application scope. Our inventive concept addresses this limitation by expanding the technology to tackle critical issues in distinct industries. For instance, in sports, concussions can have devastating long-term effects, while in transportation, driver fatigue is a significant contributor to accidents. Similarly, in healthcare, monitoring neuroplasticity in stroke patients can improve treatment outcomes, and in aviation, predicting mental workload in pilots can enhance safety.

Detailed Description of the Inventive Concept

Our inventive concept involves the development of wearable EEG sensors, processing units, and algorithms tailored to specific industries and applications. In the sports industry, our system can detect potential concussion indicators in athletes, enabling early intervention and prevention of long-term brain damage. For commercial drivers, our method analyzes EEG signals to determine fatigue levels, allowing for timely breaks and reducing the risk of accidents. In healthcare, our system tracks neural recovery in stroke patients, providing valuable insights for personalized treatment. Additionally, our concept can predict mental workload in pilots, enabling proactive measures to mitigate pilot error. Finally, our system can identify anxiety patterns in patients, facilitating early diagnosis and treatment.

Novelty and Inventive Step

The novelty of our inventive concept lies in its application of brain monitoring technology to entirely new industries and use cases. The inventive step is the adaptation of the core technology to address specific challenges in these diverse fields, resulting in novel systems and methods that were not anticipated by the original patent.

Alternative Embodiments and Variations

Alternative embodiments of our inventive concept could include the integration of additional sensors, such as electromyography (EMG) or oxygenation sensors, to provide a more comprehensive picture of brain activity. Variations of our concept could also involve the development of mobile applications or cloud-based platforms for remote monitoring and data analysis.

Potential Commercial Applications and Market

Our inventive concept has significant commercial potential across multiple industries. In the sports industry, our system could be marketed to professional teams, universities, and sports medicine centers. In transportation, our technology could be integrated into fleet management systems or sold as a standalone solution to commercial drivers. In healthcare, our system could be marketed to hospitals, rehabilitation centers, and neurology clinics. Finally, in aviation, our concept could be sold to airlines, flight schools, or integrated into pilot training programs. The market potential is substantial, with projected growth in each of these industries.

Original Patent Information

Patent NumberUS 11,857,334
TitleSystems and methods for monitoring a subject under the influence of drugs
Assignee(s)The General Hospital Corporation